Jaro Institute has listed flat at the issue price of Rs 890 per share. The stock is now down 7% from opening levels.
Let’s now take a look at the overall derails of the Rs 450 crore book-built IPO and the key highlights of the company’s business fundamentals.
Jaro Institute IPO: Subscription details
The Jaro Institute IPO saw steady support from investors. Overall, the issue was subscribed 23.20x. The retail subscription stood at 9.15x while the QIB category was subscribed 37.19 times. The NII subscription stood at 37.32x.
Jaro Institute IPO: GMP trends
The Jaro Institute IPO GMP has fallen significantly after the bidding close. The GMP while the issue was onb was trending between 10-15%. However, it continued to fall to about 5%. There are many times the actual listing is significantly different from the GMP.
Jaro Institute: Analyst views
Most brokerages see the issue fully price in at current levels. According to Anand Rathi, “at the upper price band company is valuing at P/E of 38.1x to its FY25 earnings, with EV/EBITDA of 24.8x. With a consistent track record of building long-term and resilient client relationships across industries, it ensures high revenue visibility and stability. Its portfolio reflects a proven ability to design and deliver high-quality, diverse course offerings tailored to evolving market needs. By leveraging advanced technology and digital platforms, Jaro enhances the overall experience for its clients while driving scalability and expansion.”
Deven Choksey Research report also highlighted that the company is fairly valued at current levels, “Jaro’s Initial issue is priced at 38.2x FY25 P/E, while most of its privately held peers were not profitable for the most recent years. Although the issue being priced at 38.0x, we believe the stock is attractively priced, driven by its strong revenue growth, healthy margin and return profile. We expect the Company to perform well in terms of profitability, with an increase in enrolments.”